Skip to main content

USANA HEALTH SCIENCES INC

For the period ended Apr 4, 2026. Filed May 12, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Apr 4, 2026 · Filed May 12, 2026

USNA$13.10-5.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands)

For the three months ended March 29, 2025

Common stock · Additionalpaid-incapital · Retainedearnings · Accumulatedothercomprehensiveincome (loss) · Total stockholders' equity attributable to USANA
Shares · Value
Balance at December 28, 202419,064$19$75,816$478,944$(22,670)$532,109
Net earnings attributable to USANA9,4029,402
Other comprehensive income (loss), net of tax(82)(82)
Equity-based compensation expense2,8802,880
Common stock repurchased and retired(399)—(1,662)(10,718)(12,380)
Common stock issued under equity award plans121——
Tax withholding for net-share settled equity awards(2,167)(2,167)
Balance at March 29, 202518,786$19$74,867$477,628$(22,752)$529,762

For the three months ended April 4, 2026

Common stock · Additionalpaid-incapital · Retainedearnings · Accumulatedothercomprehensiveincome (loss) · Total stockholders' equity attributable to USANA
Shares · Value
Balance at January 3, 202618,281$18$83,544$465,720$(16,178)$533,104
Net earnings attributable to USANA7,5157,515
Other comprehensive income (loss), net of tax1,7421,742
Equity-based compensation expense3,4543,454
Common stock issued under equity award plans176——
Tax withholding for net-share settled equity awards(2,265)(2,265)
Balance at April 4, 202618,457$18$84,733$473,235$(14,436)$543,550
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.